Dow Jones Business News via Dow Jones BUDAPEST --Finnish pharmaceutical company Orion OYJ has confirmed that deramciclane, Hungarian drug maker Egis' new drug, is effective against depression as well as anxiety, Schroder Salomon Smith Barney said Monday. Dow Jones Online News via NewsEdge Corporation : Dow Jones Business News via Dow Jones BUDAPEST (Dow Jones)--Finnish pharmaceutical company Orion OYJ (Y.OYH) has confirmed that deramciclane, Hungarian drug maker Egis' (R.EGS) new drug, is effective against depression as well as anxiety, Schroder Salomon Smith Barney said Monday. Orion made the confirmation at a research and development day Dec. 3, SSSB said in a report. "In preclinical models, deramciclane showed potential against anxiety and depression," SSSB quoted Esa Heinonen, Orion's head of research and development as saying. "Preclinical data suggested deramciclane would have similar chances in depression as in anxiety," Heinonen added. Deramciclane is currently under phase III clinical testing as an anti-anxiety drug. Its effectiveness for depression is likely to be a major breakthrough for Egis. (MORE) Dow Jones Newswires 12-09-02 0726ET - - 07 26 AM EST 12-09-02 DJONviaNewsEdge <> << Copyright ©2002 Dow Jones and Company, Inc. >>
VII Российский конгресс с международным участием «Молекулярные основы клинической медицины – возможное и реальное» пройдет в Санкт-Петербурге 16 декабря, 2024
Ведущий научный сотрудник НЦПЗ Ирина Федоровна Рощина награждена медалью Г.И. Челпанова 10 декабря, 2024